Literature DB >> 2230016

Seroepidemiology of hepatitis B in Nepal.

S M Shrestha1.   

Abstract

To assess the prevalence of BHV infection in Nepal sera of 2,555 healthy individuals of different age groups from different parts of the country were examined for the markers of the infection. BHsAg and anti-HBs were assayed by R-PHA and PHA methods respectively and anti-HBc by ETA method. Anti-HBc was positive in 43.5 per cent of 2,555 sera of healthy individuals in Nepal. HBsAg was in 0.9 per cent (1.5 per cent in male and 0.5 per cent in female) and anti-HBs in 7.7 per cent (7 per cent in male and 8 per cent in female). The prevalence of HBsAg and anti-HBs was higher in urban than in rural areas, and the highest prevalence of these markers was noted in health care personnels (HBsAg 2.6 per cent and anti-HBs 17 per cent). HBsAg was not detectable in infants and young children, and the highest prevalence rate was observed in 6 to 15 years age group. The main mode of spread of HBV infection in Nepal was the horizontal transmission in pre-adolescent and adolescent children. HBV infection is common in Nepal but the BHsAg carrier rate is much lower than reported from other Asian countries.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2230016

Source DB:  PubMed          Journal:  J Commun Dis        ISSN: 0019-5138


  9 in total

1.  The health system in Nepal-An introduction.

Authors:  S K Rai; G Rai; K Hirai; A Abe; Y Ohno
Journal:  Environ Health Prev Med       Date:  2001-04       Impact factor: 3.674

2.  Liver cirrhosis and hepatocellular carcinoma in hepatic vena cava disease, a liver disease caused by obstruction of inferior vena cava.

Authors:  Santosh Man Shrestha
Journal:  Hepatol Int       Date:  2009-01-23       Impact factor: 6.047

3.  Seroprevalence of HBV and HCV in blood donors: A study from regional blood transfusion services of Nepal.

Authors:  B R Tiwari; P Ghimire; S R Kandel; M Rajkarnikar
Journal:  Asian J Transfus Sci       Date:  2010-07

Review 4.  Liver Cancer in Nepal.

Authors:  Ananta Shrestha
Journal:  Euroasian J Hepatogastroenterol       Date:  2018-05-01

5.  Lives saved with vaccination for 10 pathogens across 112 countries in a pre-COVID-19 world.

Authors:  Jaspreet Toor; Susy Echeverria-Londono; Xiang Li; Kaja Abbas; Emily D Carter; Hannah E Clapham; Andrew Clark; Margaret J de Villiers; Kirsten Eilertson; Matthew Ferrari; Ivane Gamkrelidze; Timothy B Hallett; Wes R Hinsley; Daniel Hogan; John H Huber; Michael L Jackson; Kevin Jean; Mark Jit; Andromachi Karachaliou; Petra Klepac; Alicia Kraay; Justin Lessler; Xi Li; Benjamin A Lopman; Tewodaj Mengistu; C Jessica E Metcalf; Sean M Moore; Shevanthi Nayagam; Timos Papadopoulos; T Alex Perkins; Allison Portnoy; Homie Razavi; Devin Razavi-Shearer; Stephen Resch; Colin Sanderson; Steven Sweet; Yvonne Tam; Hira Tanvir; Quan Tran Minh; Caroline L Trotter; Shaun A Truelove; Emilia Vynnycky; Neff Walker; Amy Winter; Kim Woodruff; Neil M Ferguson; Katy Am Gaythorpe
Journal:  Elife       Date:  2021-07-13       Impact factor: 8.140

6.  Prevalence and risk factors of hepatitis B infection among mothers and children with hepatitis B infected mother in upper Dolpa, Nepal.

Authors:  Purusotam Raj Shedain; Madhu Dixit Devkota; Megha Raj Banjara; Huang Ling; Subash Dhital
Journal:  BMC Infect Dis       Date:  2017-10-10       Impact factor: 3.090

Review 7.  Epidemiology of Viral Hepatitis and Liver Diseases in Nepal.

Authors:  Ananta Shrestha
Journal:  Euroasian J Hepatogastroenterol       Date:  2015-01-06

Review 8.  Viral Hepatitis in Nepal: Past, Present, and Future.

Authors:  Ananta Shrestha
Journal:  Euroasian J Hepatogastroenterol       Date:  2016-07-09

Review 9.  Seroprevalence of hepatitis B and C in Nepal: a systematic review (1973-2017).

Authors:  Marcelo Contardo Moscoso Naveira; Komal Badal; Jagadish Dhakal; Neichu Angami Mayer; Bina Pokharel; Ruben Frank Del Prado
Journal:  Hepatol Med Policy       Date:  2018-09-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.